Key facts
| Recalling firm | Medtronic Navigation, Inc. |
|---|---|
| Manufacturer | Not disclosed in the FDA record. |
| Brand name | Not disclosed in the FDA record. |
| Product description | AxiEM" Non-Invasive Patient Tracker |
| Classification | Class II |
| Recall number | Z-1039-2023 |
| Report date | Not disclosed in the FDA record. |
| Status | Ongoing |
| Reason for recall | Due to increasing complaint trend for the Non-Invasive Patient Tracker system where complaints analysis indicates that users are unable to successfully verify their navigation instruments during image-guided surgery. |
What this classification means
A Class II recall is FDA’s middle classification. FDA assigns Class II when use of, or exposure to, the recalled product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote. FDA still requires the recalling firm to notify affected accounts and submit status reports on the correction, though the monitoring intensity is lower than for a Class I recall. FDA's Center for Devices and Radiological Health (for devices) or Center for Drug Evaluation and Research (for drugs) reviews the classification and can require additional corrective action if the initial response is judged insufficient. Because this record is filed as Class II, professionals and consumers handling an affected lot should treat FDA's own classification -- not this page's summary of it -- as the authoritative risk signal. A Class I recall is FDA’s most serious classification. FDA assigns Class I when there is a reasonable probability that use of, or exposure to, the recalled product will cause serious adverse health consequences or death. This classification does not mean harm has already occurred in every case -- it reflects FDA’s assessment of the realistic worst-case risk profile of the defect described in the recall, based on the reason for recall reported by the firm. Class I recalls receive the closest FDA monitoring of the three classes: the recalling firm typically must submit a recall strategy, periodic status reports, and effectiveness checks confirming that the affected lots have actually been removed from distribution or corrected in the field.
What consumers should do
Facilities, clinicians, and consumers holding an affected unit or lot of AxiEM" Non-Invasive Patient Tracker should stop using it for the purpose described in the recall notice and hold remaining stock pending instructions from Medtronic Navigation, Inc.. FDA recall records typically direct the recalling firm to notify known accounts directly with a recall letter describing the specific corrective action -- replacement, field correction, refund, or return. Anyone who received the product through a distributor rather than directly from Medtronic Navigation, Inc. should confirm with their supplier whether their specific lot or unit is on the affected list, since recall notices are lot- or unit-specific and not every unit of a product line is necessarily included. Questions about a specific unit's status should go to Medtronic Navigation, Inc. directly or to the distributor that supplied it; Argus HQ is a public-record aggregator, not the recalling firm, and cannot confirm individual unit status.
Medtronic Navigation, Inc.’s FDA history
Argus HQ has recorded 10 total FDA actions tied to Medtronic Navigation, Inc.: 0 warning letters, 10 recalls, 0 approval records, and 0 Form 483 inspection citations.
Frequently asked questions
- Is AxiEM" Non-Invasive Patient Tracker recalled?
- Yes. FDA lists a Class II recall by Medtronic Navigation, Inc. for AxiEM" Non-Invasive Patient Tracker, reported 20230208, with status "Ongoing." FDA recall number: Z-1039-2023.
- What is the recall class for Medtronic Navigation, Inc.'s recall?
- FDA classified this recall as Class II. A Class II recall is FDA’s middle classification. FDA assigns Class II when use of, or exposure to, the recalled product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
- Why was AxiEM" Non-Invasive Patient Tracker recalled?
- FDA's recall record states the reason as: Due to increasing complaint trend for the Non-Invasive Patient Tracker system where complaints analysis indicates that users are unable to successfully verify their navigation instruments during image-guided surgery.
- Who should I contact about this recall?
- Contact Medtronic Navigation, Inc. directly, or the distributor/pharmacy that supplied the product, to confirm whether your specific lot or unit is affected. Argus HQ aggregates the public FDA recall record and is not the recalling firm.
Know if this happens again — we'll email you.
Free. No spam, just recall alerts for what you tell us to watch.
Related enforcement actions
Full FDA history for Medtronic Navigation, Inc.- Recall: Medtronic Navigation, Inc. — Class II recall: Medtronic PIN, 100mm STERILE PERCUTANEOUS REF: 9733235 Medtronic PIN, 150MM,… →
- Recall: Medtronic Navigation, Inc. — Class II recall: StealthStation S8 App versions 1.3.0 and 1.3.2, (Model # 9735762) The Stealth… →
- Recall: Medtronic Navigation, Inc. — Class I recall: Stealth S8 Clinical Software Application, REF: 9735762, CE0344, Rx Only. Used i… →
- Recall: Medtronic Navigation, Inc. — Class II recall: Medtronic, REF 9733235, Pin, 100mm, STERILE, PERCUTANEOUS →
- Recall: Medtronic Navigation, Inc. — Class II recall: Medtronic, REF 9733236, Pin, 150mm, STERILE, PERCUTANEOUS →
- Recall: Medtronic Navigation, Inc. — Class I recall: StealthStation S8 Application version 2.0 and 2.0.1 (Part 9735762) The Stealt… →
- Recall: Medtronic Navigation, Inc. — Class I recall: StealthStation Cranial Software, Model: 9735585, used with StealthStation S7/i7… →
- Recall: Medtronic Navigation, Inc. — Class I recall: StealthStation Cranial Software, Models: 9735585, 9735586 (kit), 9735587 (kit),… →
Compiled by Argus HQ Research from FDA primary sources · Reviewed by Andy Gaber, Founder
Cite this record
Reusing this data in reporting or research? Here’s a ready-made citation.
Argus HQ Research (2023). Recall Record: Class II Recall: AxiEM" Non-Invasive Patient Tracker by Medtronic Navigation, Inc.. Digital Empire LLC. Retrieved from https://argushq.ai/recall/medtronic-navigation-z-1039-2023-2023-02-08
"Recall Record: Class II Recall: AxiEM" Non-Invasive Patient Tracker by Medtronic Navigation, Inc.." Argus HQ Research, Digital Empire LLC, 2023, argushq.ai/recall/medtronic-navigation-z-1039-2023-2023-02-08.
Argus HQ Research. "Recall Record: Class II Recall: AxiEM" Non-Invasive Patient Tracker by Medtronic Navigation, Inc.." Digital Empire LLC. Accessed July 17, 2026. https://argushq.ai/recall/medtronic-navigation-z-1039-2023-2023-02-08.
@misc{argushq_argushq_ai_recall_medtronic_navigation_z_1039_2023_2023_02_08_2023,
title = {Recall Record: Class II Recall: AxiEM" Non-Invasive Patient Tracker by Medtronic Navigation, Inc.},
author = {{Argus HQ Research}},
year = {2023},
publisher = {Digital Empire LLC},
url = {https://argushq.ai/recall/medtronic-navigation-z-1039-2023-2023-02-08},
note = {Accessed: July 17, 2026}
}Source: FDA.gov — Recalls ↗

